Explore more publications!

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 8, 2025

Beverly Hills Gastroenterology Practice in Beverly Hills Opens New Office
Confidia Cares Honors Local Heroes and Inspires the Next Generation with $15,000 in Community Support
Longevity Expert Establishes a New Benchmark in Consciousness Detection - New Future for Brain-Computer Interfaces?
Arthritis National Research Foundation Launches Immune Boost Capital to Accelerate Early-Stage Autoimmune Innovation
Disability Insurance: An Overlooked Safety Net for Young Adults
Dr. Thomas Murphy selected as Top Chemical Engineer of the Year by IAOTP
The Brookbush Institute Publishes a NEW Glossary Term: 'Longitudinal Study'
PR & Communications Teams Turn to Behavioral Scientists  as 52% Struggle to Prove ROI Beyond Vanity Metrics
New Guidance and Tools for Restoring Abandoned Mines
NordSpace and Kongsberg Geospatial Sign Memorandum of Understanding to Advance Canada’s Responsive Space Launch Goals
WesternU Faculty Member Publishes Breakthrough Study on Schistosome Resistance Genes
DR KARA RONCIN SELECTED TO BE FEATURED IN THE PUBLICATION TOP 50 FEARLESS LEADERS BY IAOTP
Faex Health Launches C. diff Detection Through AI-Powered Stool Image Analysis
Keystone Clinic & Surgery Opens Fourth Branch in Ghim Moh, Expanding Community Access to Primary Care
TierOne to Showcase NaaS CX, Smart NOC, and NaaS NOC Solutions at GITEX 2025
New Report Finds Harmful Plastic Chemicals in Over Half of Popular Pediatric OTC Medications
Nilo Therapeutics se lanza con un financiamiento Serie A de 101 millones de dólares para avanzar una nueva clase de medicamentos dirigidos a los circuitos neuronales en enfermedades inmunológicas y nombra a Kim Seth como director ejecutivo
Lancement de Nilo Therapeutics avec un financement de série A de 101 millions de dollars en vue de développer une nouvelle classe de médicaments ciblant les circuits neuronaux dans les maladies immunitaires, et nomination de Kim Seth au poste de…
ナイロ・セラピューティクス (Nilo Therapeutics)、免疫疾患における神経回路を標的とする新しい種類の医薬品開発を推進するため、1億100万米ドル (約154億1,290万円) のシリーズA資金調達を実施し、キム・セス博士 (Kim Seth, Ph.D.) を最高経営責任者 (CEO) に任…
Nilo Therapeutics dilancarkan dengan pembiayaan Siri A sebanyak $101 juta untuk membangunkan kelas baharu ubat-ubatan yang menyasarkan litar neural dalam penyakit imun, serta melantik Kim Seth sebagai Ketua Pegawai Eksekutif

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions